Page 6 of articles about PCV2
PCV2 vaccines: Efficacy and clinical application
The efficacy of PCV2 vaccines to control PCV2 associated diseases has been clearly demonstrated not only in piglets but also in sows. Moreover, it is also feasible to vaccinate sows and their offspring without hampering its growth during the rearing period.
A new method of diagnosis allows the detection and differentiation of five porcine viruses in a single run
Pleurisy: economic impact and strategies for management in swine farms
The prevalence of pleurisy is surprisingly high among pigs at slaughter. A recent review of available data ranged from 12.5% in the UK, 26% in Spain, to 41% of individual pigs slaughtered in one Norwegian study.
PCV2 and Mycoplasma hyopneumoniae: co-infection and co-vaccination
Experimental Mhyo and PCV2 co-inoculations have resulted in somewhat divergent results.
PCV2 infection before and during an outbreak of PMWS on a pig farm in the UK
Protective effect of the maternally derived porcine circovirus type 2 (PCV2)-specific cellular immune response in piglets by dam vaccination against PCV2 challenge
Boehringer Ingelheim Animal Health sponsors PCV2 research projects with more than 400,000 euro
Spray-dried animal plasma on weanling pigs administered a PCV2 and M. hyopneumoniae vaccine strategy
PCV2: Possible transmission to sows through artificial insemination and effects on quality of boar semen
PCV2 can be shed into semen by infected boars and research suggests that the virus can then be transmitted to gilts and sows by AI causing reproductive failure but there is no evidence that PCV2 in semen has effects on various characteristics of sperm cells.
PMWS: Disease progression and a proposal for herd case definition
Preventing disease: One billion pigs vaccinated with Ingelvac CircoFLEX®
Effect of sow and piglet porcine circovirus type 2 (PCV2) vaccination on piglet mortality, viraemia, antibody titre and production parameters
Importance and monitoring of the genetic makeup of PCV2
Genomic changes can be associated with increased virulence or decreased immunogenicity.